@article{fa55ed646e2742fca14ffd90552ff012,
title = "Bronchiectasis enters the inflammation era",
keywords = "bronchiectasis, eosinophils, exacerbations, neutrophils, treatment",
author = "Keir, {Holly R.} and Chalmers, {James D.}",
note = "Funding Information: Holly R. Keir declares no conflicts of interests. James D. Chalmers reports research grants and consultancy from Astrazeneca, Boehringer Ingelheim, Chiesi, Gilead Sciences, Glaxosmithkline, Grifols, Insmed, Novartis, Pfizer and Zambon. Funding Information: Holly R. Keir and James D. Chalmers are funded by Asthma and Lung UK.",
year = "2022",
month = jul,
doi = "10.1111/resp.14263",
language = "English",
volume = "27",
pages = "488--489",
journal = "Respirology ",
issn = "1323-7799",
publisher = "Wiley",
number = "7",
}